Acorn 3D Software (AC-SEG-4009); Acorn 3DP Model (AC-101-XX)

K252103

Mighty Oak Medical · cleared 2025-12-02 · product code QIH · Radiology

FDA 510(k) summary for Acorn 3D Software (AC-SEG-4009); Acorn 3DP Model (AC-101-XX) (K252103)

Constat organizes this clearance into predicate context, validation evidence, reported performance, postmarket signals, and reimbursement links. Each extracted claim stays tied to the public FDA source; missing fields remain explicitly unstated.

Validation studies
3
Cited predicates
2
Performance observations
3
Product code
QIH
Official FDA 510(k) database record ↗FDA 510(k) source PDF ↗

Premarket evidence — what FDA accepted

Device typesamd
source quote (p.4)
“Acorn 3D Software is a modular image processing software intended for use as an interface for visualization of medical images, segmentation, treatment planning, and production of an output file. The Acorn 3D Segmentation module contains both machine learning based auto segmentation as well as semi-automatic and manual segmentation tools. Acorn 3DP Model is an additively manufactured physical replica of the virtual 3D model generated in Acorn 3D Segmentation.”
Algorithmmachine learning algorithm, convolutional neural network called U-Net
source quote (p.13)
“Acorn 3D utilizes a machine learning algorithm to assist in the segmentation of regions of interest, with a primary focus on segmenting vertebrae from the spine in DICOM images. The algorithm produces segmentations using a convolutional neural network called U-Net, which is trained on qualified ground truth data.”
Adaptive (vs locked)No
source quote (p.12)
“In accordance with the PCCP, all algorithm modifications will be trained, tuned, and locked prior to release of the software.”
PCCPYes
source quote (p.12)
“Mighty Oak Medical will make future algorithm improvements under a Predetermined Change Control Plan (PCCP; cleared as part of K234009 – no changes made to the PCCP as part of K252103).”
Cybersecurity addressedFDA source did not state this

Validation studies (3)

Retrospective clinical

n=71 cases

endpoints: DICE similarity coefficient (DSC)

Retrospective clinical

n=40 cases

endpoints: DICE similarity coefficient (DSC)

Bench

sample size not stated

endpoints: Median TRE (mm); 3rd Quartile TRE (mm)

Reported performance (3 observations)

diceas written: “Mean DSC (Vertebral, In-House)”0.9331
source quote (p.13)
“Model: Vertebral (T1-T12, L1-L5), Testing Dataset: In-House (Mighty Oak Medical), Mean DSC: 0.9331”
diceas written: “Mean DSC (Vertebral, VERSE '20)”0.94451
source quote (p.13)
“Model: Vertebral (T1-T12, L1-L5), Testing Dataset: VERSE '20, Mean DSC: 0.94451”
diceas written: “Mean DSC (Sacral, In-House)”0.9663
source quote (p.13)
“Model: Sacral, Testing Dataset: In-House (Mighty Oak Medical), Mean DSC: 0.96630”

Each value carries its own analysis unit and task — never compare or pool across devices. Source: 510(k) summary PDF.

Predicate network

Postmarket — what happened after clearance

1
recalls in product code, 24mo
4
MAUDE reports in code, 12mo
—
vs code's own 3-yr baseline
2
drift signals on this device
  • predicate_cohort_contagion

    K252103 shares predicate K234009 with K251532 (Acorn 3D Software (AC-SEG-4009); Acorn 3DP Model (AC-101-XX)), whose product code LLZ recorded 48 recall event(s) in the trailing 24 months.

    first seen 2026-07-15 · predicate:K234009 sibling:K251532

  • recall_reason_pattern

    Software/algorithm-related recall in product code QIH (PIE Medical Imaging B.V., initiated 2026-05-07): "User measurement value reported by diagnostic bioimaging software intended to measure/visualize cardiovascular structures may be larger (0.8% to 34.4%) than the actual anatomical d" Recalling firm is another firm in the same product code.

    first seen 2026-08-26 · recall res_event_number:98930

Recall and MAUDE counts are product-code-level (reports aren't reliably attributable to one device); a recall is shown as device-attributed only when the recall record itself lists this clearance number. Signals are descriptive observables with sources — never a judgment that the device is unsafe or drifting. Snapshot 2026-08-26.

Reimbursement — how devices like this got paid

Not yet tracked — no payment pathway indexed for this clearance (the reimbursement corpus is a growing seed set).

Applicable FDA guidance — what the submission is measured against

FDA guidance documents and guiding principles applicable to 510(k) AI/ML devices in the Radiology panel. A curated reference index, not legal or regulatory advice — each item states its own status, and a draft is never binding.

Applicability is derived from the device's FDA advisory panel and pathway — cross-cutting guidances apply to every AI/ML device; panel-specific ones are flagged. Titles, dates, and links verified against fda.gov as of July 2026.

Related FDA clearances

More AI/ML devices under product code QIH

These are recent clearances in the same FDA product-code category. Shared classification does not by itself make a device an appropriate predicate.

ADAS 3D

K253969

Adas3D Medical S.L.

cleared 2026-06-29

Auto-Seg (SO-0012), Spine Auto-Seg (SO-0012)

K253628

Agada Medical, Ltd.

cleared 2026-06-29

syngo.CT Coronary Cockpit

K253786

Siemens Medical Solutions USA, Inc.

cleared 2026-06-25

CMN Capillary Function with Oncology Virtual Expert

K260316

Cercare Medical A/S

cleared 2026-06-22

Synapse PACS (7.6.0)

K261713

FUJIFILM Healthcare Americas Corporation

cleared 2026-06-18

MediAI-OA

K253172

Crescom Co., Ltd.

cleared 2026-06-15

AiORTA - Plan v2.0

K254207

ViTAA Medical Solutions, Inc.

cleared 2026-03-30

SwiftMR

K253775

Airs Medical, Inc.

cleared 2026-03-26

Constat Precedent · public FDA/CMS data · descriptive decision-support, not regulatory or reimbursement advice. Share this page: constat.dev/precedent/device/K252103